The Annexure

News to 16 October 2026 ·

Desk›Healthcare› Anthem Biosciences Ltd

Anthem Biosciences Ltd

BSE 544449 · NSE ANTHEM · ISIN INE0CZ201020 · Group A · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Biotechnology

₹900.60

-2.54%

BSE close, 28 August 2026

Market cap

₹50,740.53 cr

56.3 cr shares · Mid cap

Free float

₹9,689.97 cr

as published

P/E · P/B

81.3× · —

EPS ₹11.08 · BV —

FY25-26 rev / PAT

2,089.31 / 670.56

₹ cr, as filed

Filings, window

4

1 selected · 25%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹579.45 52-WK HIGH ₹942.00 ₹900.60 89% of range
Against 52-week high-4.4%
Against 52-week low+55.4%
Day change-2.54%
Size bandMid cap
Index membershipNIFTY 500

Valuation as published by BSE

Earnings per share₹11.08
Price / earnings81.28×
Price / book—
Book value — derived, price ÷ P/B—
Return on equity—
Operating margin41.54%
Net margin26.58%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 383.84 102.01 1.81 41.54% 26.58%
Mar-26 · Q 582.50 211.66 3.77 56.41% 36.34%
FY25-26 2,089.31 670.56 11.95 48.30% 32.09%

Quarter on quarter

Revenue, quarter on quarter
-34.1%
Net profit, quarter on quarter
-51.8%
Operating margin, quarter on quarter
-1,487 bps

Disclosure profile 4 filings in the window

0 median 17.0 p75 · 24 sector max 59 4 4th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 24 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Concall Transcript1
Selected sub-total1
Procedural
Compliance Certificate1
General1
Trading Window1
Procedural sub-total3
Total4

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 98 trading days

4 filings · 1 selected · busiest 2026-07-27 and 2026-09-08

Filing rhythm · the twelve most recent

2026-07-272026-10-09

SelectedProcedural

Filings

4 in the window · 24 earlier on record

  1. 9 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance Certificate under Reg 74(5) of DP Regulations

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 24 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of closure of Trading Window for Q2FY27

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 8 September 2026 ·

    General

    Settlement Of Upside Sharing Arrangement

    Intimation of the settlement of Upside Sharing Arrangement

    Company Update / General View filing →

  4. 27 July 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Transcript of Earnings Conference Call held on July 22, 2026.

    Company Update / Earnings Call Transcript View filing →

RSS feed for Anthem Biosciences Ltd · the 50 most recent filings